Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Humana Inc (HUM.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (US$)	Price Target (US$)	Rating
2022-03-30	439.39	486.00	Neutral
2022-04-13	458.78	520.00	Buy
2022-04-27	443.37	532.00	Buy
2022-07-28	484.01	550.00	Buy
2022-10-10	497.04	585.00	Buy
2022-11-02	559.58	645.00	Buy
2023-02-02	489.77	620.00	Buy
2023-07-13	424.29	560.00	Buy
2023-08-02	483.75	585.00	Buy
2024-01-18	411.98	530.00	Buy
2024-01-25	355.36	370.00	Neutral
2024-04-01	317.89	334.00	Neutral
2024-04-24	315.98	326.00	Neutral
2024-07-31	361.61	380.00	Neutral
2024-10-04	240.03	250.00	Neutral
2025-02-24	255.00	285.00	Neutral

Disclosures

UBS Securities LLC makes a market in the securities and/or ADRs of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.